catechin has been researched along with B-Cell Lymphoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, Y; Huang, X; Luo, X; Shen, X; Wang, J; Xie, Y; Zhang, L | 1 |
| He, J; Kondo, T; Noda, C; Takano, T; Tanaka, C; Tohyama, K; Tohyama, Y; Yamamura, H | 1 |
2 other study(ies) available for catechin and B-Cell Lymphoma
| Article | Year |
|---|---|
(-)-Epigallocatechingallate induces apoptosis in B lymphoma cells via caspase-dependent pathway and Bcl-2 family protein modulation.
Topics: Antineoplastic Agents; Apoptosis; Caspases; Catechin; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Humans; Lymphoma, B-Cell; Proto-Oncogene Proteins c-bcl-2; Signal Transduction | 2015 |
Induction of apoptosis by epigallocatechin-3-gallate in human lymphoblastoid B cells.
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Catechin; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Humans; Lymphoma, B-Cell; Reactive Oxygen Species; Signal Transduction | 2007 |